TMPC

At the end of 2012, Ian Boulton was asked to present on malaria diagnosis in the private retail sector at the 11th Assises Panafricaines de Lutte Contre le Paludisme (11th Pan-African National Malaria Control Programmes Meeting), sponsored and organised Sanofi, under the title:- Mise à disposition des TDR dans le marché privé dans un contexte de T3; faisabilité, risques et opportunités? (Availability of RDTs in the private market within the context of T3, feasibility challenges and opportunities) This presentation built upon TMPC’s work on the Affordable Medicines Facility – malaria (AMFm) and the need to extend the use of diagnosis of malaria into the private market. This was also in the context of the launch of the World Health Organization’s “Test: Treat: Track” strategy for malaria.

In May 2011, the African Leaders’ Malaria Alliance (ALMA), the Global Fund, the Medicines for Malaria Venture (MMV), and the Roll Back Malaria Partnership sponsored a Forum for Africa-based Pharmaceutical Manufacturers and Potential Investors in Nairobi. It aimed to bring together manufacturers and potential investors or technical collaborators and facilitate communication between them, with the aim of stimulating the development of a world class pharmaceutical manufacturing industry in Africa.

In December 2008, Ian Boulton was asked to present on “A Private Sector Perspective” at an Academy of Medical Sciences Conference Global Health Diagnostics: Research, Development, & Regulation. Founded in 1998, the Academy of Medical Sciences is the independent body in the UK that represents the diverse spectrum of medical science – from basic research through clinical application to healthcare delivery.

In 2006, the Dutch Ministry of Foreign Affairs, the European & Developing Countries Clinical Trials Partnership (EDCTP), and the Netherlands-African partnership for Capacity development and Clinical interventions Against Poverty-related diseases (NACCAP) organised a Stakeholder Forum on the challenges of treating poverty-related diseases. It brought together representatives from academia, industry, governments and non-governmental organisations to debate: “Connecting the Chain: Towards a comprehensive approach to delivering affordable medicines against poverty-related diseases”.